YPSOMED HLDG/ CH0019396990 /
2024-03-28 5:30:28 PM | Chg. +0.50 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
360.50CHF | +0.14% | 7,329 Turnover: 2.63 mill. |
355.00Bid Size: 56 | 367.00Ask Size: 15 | 4.92 bill.CHF | 0.36% | 94.37 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 3.82 CHF | 108.74% |
EPS Diluted: | - CHF | 108.74% |
Revenues per Share: | 36.44 CHF | -0.82% |
Book Value per Share: | 41.20 CHF | 32.77% |
Cash Flow per Share: | 9.49 CHF | - |
Dividend per Share: | 1.30 CHF | 116.67% |
Total | in mill. | |
Revenues: | 497.46 CHF | 7.03% |
Net Income: | 51.28 CHF | 121.97% |
Operating Cash Flow: | 129.53 CHF | - |
Cash and Cash Equivalents: | 25.22 CHF | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 94.37 | 50.37 |
P/S Ratio: | 9.89 | 5.28 |
P/BV ratio: | 8.75 | 4.67 |
P/CF Ratio: | 37.99 | 20.27 |
PEG: | 0.87 | 0.46 |
Earnings Yield: | 1.06% | 1.99% |
Dividend Yield: | 0.36% | 0.68% |
Market Capitalization | ||
Market Capitalization: | 4.92 bill. CHF | 2.63 bill. CHF |
Free Float Market Cap.: | - CHF | - CHF |
Market Cap. / Employee: | - CHF | - CHF |
Shares Outstanding: | 13.65 mill. |
Profitability
Gross Profit Margin: | 28.26% |
EBIT Margin: | 12.18% |
Net Profit Margin: | 10.31% |
Return on Equity: | 9.12% |
Return on Assets: | 5.95% |
Financial Strength
Liquidity I / Cash Ratio: | 9.74% |
Liquidity II / Quick Ratio: | 45.78% |
Liquidity III / Current Ratio: | 80.44% |
Debt / Equity Ratio: | 53.27% |
Dynam. Debt / Equity Ratio: | 231.25% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - CHF |
Revenues / Employee: | - CHF |
Net Income / Employee: | - CHF |
Total Assets / Employee: | - CHF |
* Fiscal Year End: | 2023-03-31 |
Accounting Standard: | Swiss GAAP FER |
Currency: | CHF |